Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
Wolfgang Hohenforst-Schmidt,1 Paul Zarogoulidis,2,3 Kaid Darwiche,3 Thomas Vogl,4 Eugene P Goldberg,5 Haidong Huang,6 Michael Simoff,7 Qiang Li,6 Robert Browning,8 J Francis Turner,9 Patrick Le Pivert,10 Dionysios Spyratos,2 Konstantinos Zarogoulidis,2 Seyhan I Celikoglu,11 Firuz Celikoglu,11 Johann...
Main Authors: | Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vogl T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Le Pivert P, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/intratumoral-chemotherapy-for-lung-cancer-re-challenge-current-targete-a13696 |
Similar Items
-
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8+T Cell Immunity
by: Domvri K, et al.
Published: (2022-09-01) -
Case Report: Endoscopic radiofrequency ablation with radial-EBUS and ROSE
by: Paul Zarogoulidis, et al.
Published: (2023-01-01) -
Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment
by: Pitsiou G, et al.
Published: (2014-10-01) -
Reduction of exercise capacity in sarcoidosis in relation to disease severity
by: Kallianos A, et al.
Published: (2015-08-01) -
Innovative use of a Montgomery cannula in the bronchoscopic management of tracheal stenosis and failed tracheostomy decannulation
by: Haidong Huang, et al.
Published: (2017-01-01)